Sigmanomics
Back to all insights

Breaking News: Securities Class Action Filed Against Applied Therapeutics Inc. – What Investors Need to Know

Breaking News: Securities Class Action Filed Against Applied Therapeutics Inc. – What Investors Need to Know

Description:

BENSALEM, Pa.–(BUSINESS WIRE)–Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024, inclusive (the “Class Period”). Applied Therapeutics investors have until February 18, 2025 to file a lead plaintiff motion. Investors suffering losses on their Applied Therapeutics investments are encoura.

What Happened?

Investors who purchased securities of Applied Therapeutics Inc. are now facing a securities class action lawsuit. The lawsuit alleges that the company failed to disclose certain information that may have impacted the stock price. This has resulted in losses for investors who bought the securities during the specified Class Period.

What Investors Need to Know:

If you are an investor who purchased securities of Applied Therapeutics Inc. between January 3, 2024, and December 2, 2024, you may be eligible to participate in the class action lawsuit. It is important to seek legal advice and understand your rights as an investor. The deadline to file a lead plaintiff motion is February 18, 2025, so act promptly if you believe you have suffered losses.

How Will This Affect You?

As an investor in Applied Therapeutics Inc., this class action lawsuit could have financial implications for you. If the allegations are proven true, it may result in a decrease in the stock price and potential losses for investors. It is crucial to stay informed about the developments of the lawsuit and consider your options moving forward.

How Will This Affect the World?

Securities class action lawsuits against companies like Applied Therapeutics Inc. can have broader implications for the financial markets and investor confidence. The outcome of this lawsuit may set a precedent for how companies disclose information to investors, affecting transparency and accountability in the business world.

Conclusion:

Investors who purchased securities of Applied Therapeutics Inc. should be aware of the class action lawsuit filed against the company. Seeking legal advice and understanding your rights as an investor is crucial in this situation. Stay informed about the developments of the lawsuit and consider how it may impact your investments moving forward.

more insights

“Breaking News: Senator Cynthia Lummis Takes the Helm of New Congressional Panel Focused on Bitcoin and Crypto Assets!”

January 23, 2025

Pro-crypto Wyoming Senator Cynthia Lummis Named Chair of Senate Panel on Digital Assets Introduction Pro-crypto Wyoming Republican Senator Cynthia Lummis has made history by becoming the first-ever chair of the new Senate panel dedicated to digital assets. This is a significant development in the world of cryptocurrency, showing that government

Read more >

“Unlocking the Potential: Algorand’s Price Set to Soar with a 50% Surge in Active Addresses and Transactions!”

January 23, 2025

Algorand Price Movement After Donald Trump’s Inauguration Impact on Algorand (ALGO) and Other Altcoins This week, Algorand’s price moved sideways, reflecting the performance of most altcoins following Donald Trump’s inauguration. Algorand (ALGO), a top layer-2 network, was trading at $0.4165, which is approximately 16% below its highest level last week.

Read more >
Sigmanomics

Menu

About

News

Signals

Risk Disclaimer: Sigmanomics is a financial portal that provides news and analysis about the different financial markets. The articles that we serve on the portal depend solely on the opinion and analysis of our economists which in no way are intended to incite a visitor of the website or an investor to trade or sell/buy a certain instrument. It is the responsibility of the visitor / trader only to evaluate his trading strategies and whether he is capable of trading with taking into consideration that losing all the capital invested is a possibility. The visitor should seek an independent professional financial advisor to discuss his or her trading strategies. Moreover, the provided rates for the different instruments are indicative only and cannot be used for trading purposes. Therefore, no responsibility can be imposed on sigmanomics.com.com and the company operating the portal for any loss of money that may occur to the visitor by using the website.